3D Bioprinting and Intellectual Property Considerations€¦ · 16-03-2016 · 3D Bioprinting and...
Transcript of 3D Bioprinting and Intellectual Property Considerations€¦ · 16-03-2016 · 3D Bioprinting and...
-
3D Bioprinting and
Intellectual Property Considerations
Cyfuse Biomedical K.K. Jiro (Joe) Ono
LifeNet Health Jingsong Chen, M.D.
Crowell & Moring LLP Lisa A. Adelson [email protected]
Michael H. Jacobs [email protected]
mailto:[email protected]:[email protected]:[email protected]:[email protected]
-
3D Printing Market Overview
2
Traditional sectors in the 3D printing market: • Automotive • Aerospace • Industrial (e.g., power generation equipment, such
as turbines) • Consumer (e.g., appliances, razors, toothbrush
heads) • Medical (e.g., insulin pen injectors)
-
What Is Traditional 3D Printing?
3
• Process for making a physical object from a three-dimensional digital model, typically by placing numerous successive layers of material.
• Referred to as “additive” manufacturing.
-
Jiro (Joe) Ono
• Mr. Ono has experience as an international business development manager in the life sciences field.
• Mr. Ono manages Sales & Marketing for
Cyfuse, which has installed four bioprinters in North America.
4
-
What Is 3D Bioprinting?
5
Scaffold Free 3D Tissue Fabrication
No Gel. No Scaffold. Only Cells.
Cyfuse Biomedical K.K.
-
Regenova
6
4㎜ 4㎜
10mm
Kenzan 9x9 Standard Type
26 x 26 Standard Type
-
Regenova Process Flow
7
Step 2: Printing Step 1:
Spheroid Prep
500um Approx. 20,000 cells
Cells
Most of constructive cells are usable.
Form spheroid in 96-well plate for 24 hr.
Print on needle array; takes a few hours.
Mature in bioreactor for 2 to 7 days.
Step 3: Maturation
-
Step 1: Spheroid (Cell Aggregate) Preparation
8
500um
Approx. 20,000 cells
Cell
Spheroid
Low Attach Plate
• Nothing is added. • Cells aggregate
by themselves. • Cells are alive inside.
-
Step 2: 3D Printing into the Kenzan
9
Spheroid
• Nozzle picks up spheroid by vacuum and places as 3D designed.
• Spheroid is spatially held by needle.
Pick & Place
Printed
-
Step 3: Maturation
10
• Medium flow between spheroids improves oxygen and nutrient supply.
• Lift up plate for removal.
2~7 Days
Matures in Perfusion Chamber
• Cells fuse together and generate ECM.
Becomes a solid structure
-
Scaffold-Free Tissue Fabrication
11
In Vivo Transplantation
In Vitro Research Model
Nerve Graft Cancer Model Blood Vessel Hepatocyte Toxicity Test
• No foreign materials • Less proving • Reproducible
• In vivo-like environment • Visually observable • Reproducible
-
Self Organization
12
Inside spheroid Hepatocyte (Black): Outside Endothelial cells (Green): inside
4 days after printing
Print 3D structure
Hepatocyte Endothelial cells
Endothelial cells relocate to surfaces in 3D printed tissue
-
Hybrid Type
13
-
Regenova/Kenzan Method: A World of Possibilities
14
Examples • Blood vessel • Liver • Nerve • Heart • Cartilage
-
A BLOOD VESSEL!
15
-
Jingsong Chen, M.D.
• Dr. Chen is a physician/scientist with experience in translational research, new technology innovation, and business management.
• Dr. Chen is Vice President of Intellectual Property,
General Manager for the Life Sciences Division of LifeNet Health, the world’s largest provider of bio-implants and organs.
16
-
Institute of Regenerative Medicine
17
-
LifeNet’s 3D Bioprinter
18
-
3D Bioprinting Is Applicable to Implants
19
-
Real World Applications for Bioprinting
• What is LifeNet doing with bioprinting? • Results with LifeNet’s bioprinter
20
-
Lisa A. Adelson • Ms. Adelson is a Counsel at Crowell & Moring. She is
a patent attorney with extensive experience in patent prosecution and counseling, including managing patent portfolios and conducting analyses related to major due diligence and patent litigation matters.
• Ms. Adelson is a chemist by training and has broad-
ranging technical experience, including representing clients in the fields of biotechnology, pharmaceuticals, and industrial design.
21
-
Michael H. Jacobs • Mr. Jacobs is a partner in the Intellectual
Property Group at Crowell & Moring and currently serves as the Group's vice-chair.
• Mr. Jacobs focuses on patent, trademark,
trade secret, and copyright infringement litigation, post-grant patent proceedings, intellectual property portfolio management, patent procurement, counseling, and licensing.
22
-
3D BIOPRINTING IS NEW AND IT IS HERE!
23
As lawyers, how do we adapt to protect the results of 3D
bioprinting?
-
The Same 5 Arrows…
24
• Utility Patents • Design Patents • Trademarks and Trade Dress • Copyrights • Trade Secrets
-
Utility Patents
• 35 U.S.C. § 101, Utility (statutory subject matter) • 35 U.S.C. § 112
– Written description – Enablement – Best mode
• 35 U.S.C. § 102, Novelty • 35 U.S.C. § 103, Non-obviousness
25
-
Possible Utility Patent Protection
26
• Utility Patents – Obtain patents related to bioprinted tissues
• How does bioprinted tissue differ from native tissue?
• Section 101 issues
– Obtain patents to new, improved printing machines or components of those machines
– Obtain patents related to methods of printing – Obtain patents related to new cell culture media,
new techniques, etc., used in printing.
-
Design Patents
27
35 U.S.C. § 171
“Whoever invents any new, original and ornamental design for an article of manufacture may obtain a patent therefor, subject to the conditions and requirements of this title.”
+
35 U.S.C. § 112 35 U.S.C. § 102 35 U.S.C. § 103
-
Possible Design Patent Protection
• New machines
• New features of machines
• New instruments (e.g., Kenzan apparatus itself, tools for transferring cell aggregates, etc.)
28
-
Trademark and Trade Dress Protection
A trademark is “any word, name, symbol or device (or any combination thereof) that identifies and distinguishes the source of the goods of one party from those of others.”
A trade dress is the overall commercial image (look and feel) of a product or service that indicates or identifies the source of the product or service and distinguishes it from those of others.
29
-
Protectable under the Lanham Act
• Section 1 (for registered marks), codified at
15 U.S.C. § 1051 • Section 43(a) (for unregistered marks),
codified at 15 U.S.C. § 1125
30
-
DISTINCTIVE
AND
NON-FUNCTIONAL
Requirements for Trade Dress Protection
31
-
PRODUCT PACKAGING
(may be inherently distinctive)
VS.
PRODUCT DESIGN (requires secondary meaning)
TREATMENT OF DISTINCTIVENESS IS DISTINCT
32
-
Trade Dress May Not Be Purely Functional Feature is functional if:
• Essential to use or purpose • Exclusive use puts competitors at non-
reputational disadvantage
Underlying policy rationale: a useful or necessary feature should not be monopolized for unlimited term by trademark laws.
33
-
Enhancing Trademark Protection • Apply mark (e.g., logo) to, or better
yet, into bioprinted materials
• Develop additional commercially identifiable features (e.g., shape, color)
• Ensure that these features *** IDENTIFY and DISTINGUISH ***
34
-
Possible Trademark/Trade Dress Protection
• Color bioprinted products with FDA-approved
coloring agent • Utilize identifiable, non-functional shape • Etch trademark on products • Apply trademark to product packaging
35
-
Copyright Protection
36
“Copyright protection subsists, in accordance with this title, in original works of authorship fixed in any tangible medium of expression….”
17 U.S.C. § 102
-
Possible Copyright Protection
37
Copyrights © • CAD files containing digital blueprints for 3D printed
biological tissue may be copyrighted • Control software for machinery
No copyright protection for tissues themselves!
-
Copyright Term
For works created on or after January 1, 1978,
• For solo creator, author’s life plus 70 years • For a joint work, 70 years after the last surviving
author’s death
• For works for hire, 95 years from first publication, or 120 years from creation, whichever is shorter
38
-
Increased Appeal of Trade Secret
• Some products/processes may be less
amenable to patent protection. • Traditionally protected under state law;
federal protection now available.
39
-
Defend Trade Secrets Act 2016 (DTSA)
“An owner of a trade secret that is misappropriated may bring a civil action under this subsection if the trade secret is related to a product or service used in, or intended for use
in, interstate or foreign commerce.” 18 U.S.C. § 1836(b)(1).
• Effective May 11, 2016
• Three year statute of limitations 40
-
Benefits of DTSA
• Uniform definition of trade secrets • Uniform standard for misappropriation • Nationwide service of process • Nationwide execution of judgments
41
-
What Is A Trade Secret? “[T]he term ‘trade secret’ means all forms and
types of financial, business, scientific, technical, economic, or engineering information, including patterns, plans, compilations, program devices,
formulas, designs, prototypes, methods, techniques, processes, procedures, programs, or
codes, whether tangible or intangible, and whether or how stored, compiled, or memorialized
physically, electronically, graphically, photographically, or in writing.”
18 U.S.C. § 1839(3).
42
-
What Is Misappropriation? (A) acquisition of a trade secret of another by a person who knows or has reason to know that the trade secret was acquired by improper means; or (B) disclosure or use of a trade secret of another without express or implied consent by a person who—
(i) used improper means to acquire knowledge of the trade secret; (ii) …knew or had reason to know that the knowledge of the trade secret
was— (I) derived from or through a person who had used improper means … (II) acquired under circumstances giving rise to a duty to maintain the secrecy of the trade secret or limit the use of the trade secret; or (III) derived from or through a person who owed a duty to the person seeking relief to maintain the secrecy … or limit the use of the trade secret; or (iii) …knew or had reason to know that—
(I) the trade secret was a trade secret; and (II) knowledge of the trade secret had been acquired by accident or mistake . . . .
18 U.S.C. § 1839(5).
43
-
Possible Trade Secret Protection
• Favored configuration of spheroids • Favored cell types • Preferred settings for equipment • Specialized new media for maturation • Timing of steps
44
-
Trade Secret Applicability
• Reverse engineering is not possible • Restriction of access while still utilizing secret
information • Protection is desired for longer than patent term • Infringement difficult to detect or hard to enforce • Customers receive benefits without knowing
secret information
45
-
Steps To Protect Trade Secrets • Need-to-know access to a limited number of people • Employees sign confidentiality agreements and are
drilled in protection of proprietary information • Non-disclosure agreements for outsiders • Visitors escorted and forbidden from taking photos • Contractors vetted before receiving information • Labs/files/formulae locked or guarded • Mark documents • Documents/files containing secret information signed
out
46
-
LAST,
BUT REALLY FIRST,
Identify trade secret information!
47
-
Back to Reality…
• What has LifeNet found useful in seeking
Intellectual Property rights related to bioprinting?
• What has LifeNet found to be challenging?
48
-
Other Areas of Law Likely To Be Impacted by Bioprinting
• Product liability
– Safety of bioprinted materials • Regulatory issues
– FDA approval of bioprinted materials – Advertising of bioprinted materials
• Corporate issues – Technology transfer – Common interest and joint research agreements
49
-
Questions?
50
-
3D Bioprinting and
Intellectual Property Considerations
Cyfuse Biomedical K.K. Jiro (Joe) Ono
LifeNet Health Jingsong Chen, M.D.
Crowell & Moring LLP Lisa A. Adelson [email protected]
Michael H. Jacobs [email protected]
mailto:[email protected]:[email protected]:[email protected]:[email protected]
3D Bioprinting �and �Intellectual Property Considerations3D Printing Market OverviewWhat Is Traditional 3D Printing?Jiro (Joe) OnoWhat Is 3D Bioprinting?RegenovaRegenova Process FlowStep 1: Spheroid (Cell Aggregate) PreparationStep 2: 3D Printing into the Kenzan Step 3: Maturation�Scaffold-Free Tissue FabricationSelf Organization�Hybrid Type�Regenova/Kenzan Method:�A World of Possibilities�A BLOOD VESSEL!Jingsong Chen, M.D.Institute of Regenerative MedicineLifeNet’s 3D Bioprinter3D Bioprinting Is Applicable to ImplantsReal World Applications for BioprintingLisa A. AdelsonMichael H. Jacobs3D BIOPRINTING IS NEW�AND IT IS HERE!The Same 5 Arrows…Utility PatentsPossible Utility Patent ProtectionDesign PatentsPossible Design Patent ProtectionTrademark and Trade Dress ProtectionProtectable under the Lanham ActRequirements for Trade Dress ProtectionTREATMENT OF DISTINCTIVENESS �IS DISTINCT�Trade Dress May Not Be Purely Functional�Enhancing Trademark ProtectionPossible Trademark/Trade Dress ProtectionCopyright ProtectionPossible Copyright ProtectionCopyright TermIncreased Appeal of Trade SecretDefend Trade Secrets Act 2016 (DTSA)Benefits of DTSA What Is A Trade Secret?What Is Misappropriation?Possible Trade Secret ProtectionTrade Secret ApplicabilitySteps To Protect Trade SecretsLAST,Back to Reality…Other Areas of Law Likely To Be Impacted by BioprintingSlide Number 503D Bioprinting �and �Intellectual Property Considerations